Synthetic Cannabinoid use in a Case Series of Patients with Psychosis Presenting to Acute Psychiatric Settings: Clinical Presentation and Management Issues

Background: Novel Psychoactive Substances (NPS) are a heterogeneous class of synthetic molecules including synthetic cannabinoid receptor agonists (SCRAs). Psychosis is associated with SCRAs use. There is limited knowledge regarding the structured assessment and psychometric evaluation of clinical p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonaccorso, Stefania, Metastasio, Antonio, Ricciardi, Angelo, Stewart, Neil, Jamal, Leila, Rujully, Naasir-Ud-Dinn, Theleritis, Christos, Ferracuti, Stefano, Ducci, Giuseppe, Schifano, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071094/
https://www.ncbi.nlm.nih.gov/pubmed/30011896
http://dx.doi.org/10.3390/brainsci8070133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071094/
https://www.ncbi.nlm.nih.gov/pubmed/30011896
http://dx.doi.org/10.3390/brainsci8070133

Ejemplares similares